Artal Group
LUXEMBOURG, N4files as Artal Group S.A.
$931m in 2 US stocks at the end of 30 June 2026. The top 10 are 100.0% of the money. It changed about 21.3% of the portfolio this quarter.
Value
$931m
Stocks
2
Top 10 share
100.0%
Turnover
21.3%
What changed this quarter
New
Bought for the first time this quarter.
None this quarter.
Added
Bought more of a stock they already held.
- Lexicon PharmaceuticalsLXRX45.1% of the fund+13%
Cut
Sold some of their stake.
- Cava GroupCAVA54.9% of the fund-32%
Sold out
Sold their entire stake.
None this quarter.
Holdings
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| Cava GroupCAVA | 54.9% | $511m | 6,507,990 | -32% |
| Lexicon PharmaceuticalsLXRX | 45.1% | $420m | 175,156,062 | +13% |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is up 0.1% since 30 June 2025.
Where the money is
Retail & consumer54.9%
Health care45.1%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.